CIDP pursues anti-pollution and sun care substantiation claims

By Natasha Spencer

- Last updated on GMT

CIDP pursues anti-pollution and sun care substantiation claims

Related tags Ultraviolet Clinical trial

The Centre International de Développement Pharmaceutique (CIDP), a Mauritius-based private and independent Contract Research Organisation (CRO), focuses on blue light study protocol and its personal care developments after obtaining ISO-certification.

Environmental concerns

With pollution-related concerns on consumers’ radar in APAC and around the world, CIDP has developed a comprehensive protocol designed to affirm anti-pollution claims relating to cosmetics and personal care items.

As multifunctionality continues to gauge interest in manufacturers, brands and consumers alike, producers seek to support anti-pollution claims and utilise botanical ingredients.

“We’ve received a lot of interest from cosmetic manufacturers for support in claims substantiation, as well as for our unique ingredients extracted from botany that’s native to Mauritius,”​ said Jean-Louis Roule, CEO of CIDP.


Directing its R&D efforts towards the biotechnology field and quality management processes, CIDP will centre its efforts on ensuring the standards of its five centres in Mauritius, Brazil, India, Romania, and Singapore meet with international requirements.  

All of CIDP’s five centres now have ISO 9001:2015 certification following the finalisation of audits by independent certification bodies.

Blue Light Claims Substantiation

Following the success of substantiated claims relating to anti-pollution, CIDP continues to build confidence in the cosmetics and environment cross-industry sector through establishing clinical studies and designs relating to blue light.

CIDP is now launching a new study protocol that will determine the photoprotective effect of products against blue light-induced pigmentation.

“Protection from blue light exposure is a relatively new concept that consumers are starting to be more aware of,”​ announced Jessen Curpen, Biophysics Manager and Head of Clinical Study Design at CIDP.

While research in the personal care industry has tested sunscreens efficacy in protecting the skin against UVA and UVB sunlight components, recent research indicates how blue light (400 – 470 nm) causes considerable and detrimental cutaneous pigmentation effects.

At the 14th International Sun Protection Conference,held from 6–7 June 2017 in London, UK, Jessen Curpen, Biophysics Manager and Head of Clinical Study Design at CIDP, will discuss the cutaneous pigmentation effect of blue light, current UVA/UVB tests and explore new methodologies surrounding photoprotective evaluation to protect against blue light-induced pigmentation.

Related news

Follow us


View more



Beauty 4.0 Podcast